What items comprise the drug information portion of the study notebook?

• A. Marketing brochures
• B. Insurance documents
• C. Investigator brochure, drug data sheet, and package inserts
• D. Patient consent forms

Answer: (C)

The drug information portion of the study notebook brings together authoritative documents that provide detailed, official information about the investigational product to ensure safe and compliant use. The Investigator brochure compiles all available preclinical and clinical data about the drug, helping investigators understand risks, pharmacology, and prior study results. The drug data sheet offers essential, up-to-date information for researchers on dosing, administration, safety precautions, and handling. Package inserts contain labeling approved by regulators and include indications, dosing guidelines, contraindications, adverse reactions, and other labeling details.

These documents together give a complete, official reference for how the drug is expected to be used in the study and what risks to monitor. Marketing brochures and insurance documents aren’t focused on the clinical use or safety profile of the drug in a trial, and patient consent forms address consent and rights rather than providing drug-specific information.